Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPF.L Share News (APF)

  • There is currently no data for APF

Tuesday broker round-up

Tue, 02nd Apr 2019 12:14
(Sharecast News) - easyJet: Berenberg upgrades to hold with a target price of 1,040p.Arrow Global Group: Berenberg reiterates sell with a target price of 160p.i3 energy: Canaccord reiterates speculative buy with a target price of 190p.YouGov: Berenberg reiterates buy with a target price of 620p.Next Fifteen Communications: Berenberg reiterates buy with a target price of 680p.WH Smith: Peel Hunt reiterates buy with a target price of 2,500p.Anglo Pacific Group: Peel Hunt reiterates buy with a target price of 213p.Mitchells & Butlers: Liberum reiterates hold with a target price of 270p.Anglo American: Deutsche Bank upgrades to buy with a target price of 2,400p.AstraZeneca: UBS downgrades to sell with a target price of 5,400p.Travis Perkins: UBS reiterates neutral with a target price of 1,350p.Diageo: Barclays initiates at overweight with a target price of 3,470p.Hargreaves Lansdown: Citigroup upgrades to neutral.Britvic: Barclays initiates at equal weight with a target price of 960p.

Related News

AstraZeneca's Enhertu wins first EU tumour-agnostic approval for HER2
6 hours ago

AstraZeneca's Enhertu wins first EU tumour-agnostic approval for HER2

(Alliance News) - AstraZeneca PLC on Monday said the European Commission has approved Enhertu as the first tumour-agnostic HER2-directed therapy and a...

LONDON BRIEFING: BT, Verizon merge international arms in joint venture
7 hours ago

LONDON BRIEFING: BT, Verizon merge international arms in joint venture

(Alliance News) - BT and Verizon form international joint venture, Foresight increases its dividend while Plus500 adds to its US prediction markets of...

AstraZeneca's Datroway and Enhertu candidates receive EU approval
7 hours ago

AstraZeneca's Datroway and Enhertu candidates receive EU approval

(Sharecast News) - Drugmaker AstraZeneca said on Monday that its breast cancer therapy Datroway has been recommended for approval in the EU as a first...

APF.L News

DIRECTOR DEALINGS: Litigation Capital chair and CEO buy after results
27 Sep 2022

DIRECTOR DEALINGS: Litigation Capital chair and CEO buy after results

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and no...

TRADING UPDATES: Neometals swings to loss; Funding Circle strikes deal
23 Sep 2022

TRADING UPDATES: Neometals swings to loss; Funding Circle strikes deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

IN BRIEF: Anglo Pacific sees interim revenue surge on good prices
25 Aug 2022

IN BRIEF: Anglo Pacific sees interim revenue surge on good prices

Anglo Pacific Group PLC - London-based natural resources royalty company - Pretax profit for the first half of 2022 multiplies to USD130.0 million fro...

RBC Capital Markets slightly lowers target price on Anglo Pacific
2 Aug 2022

RBC Capital Markets slightly lowers target price on Anglo Pacific

(Sharecast News) - Analysts at RBC Capital Markets moved their target price on mining giant Anglo Pacific slightly lower on Tuesday, citing near-term ...

LONDON BROKER RATINGS: RBC resumes National Express at 'outperform'
2 Aug 2022

LONDON BROKER RATINGS: RBC resumes National Express at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: